Please Wait.....
Report
North America In-Vitro Toxicology Testing Market - Industry Trends and Forecast to 2030
Market Report I 2023-09-01 I 175 Pages I Data Bridge Market Research
The North America in-vitro toxicology testing market is expected to reach USD 11,902.69 Million by 2030 from USD 4,163.02 Million in 2022, growing at a CAGR of 14.0% during the forecast period of 2023 to 2030.
Market Segmentation
North America In-Vitro Toxicology Testing Market, By Product and Service (Consumables, Services, Assays, Equipments, and Software), Toxicology End Point and Test (ADME (Absorption, Distribution, Metabolism, & Excretion) Testing, Cytotoxicity Testing, Genotoxicity Testing, Dermal Toxicity Testing, Ocular Toxicity Testing, Organ Toxicity Testing, Skin Irritation, Corrosion, & Sensitization Testing, Phototoxicity Testing, and Other Toxicity Endpoints & Tests), Technology (Cell Culture Technologies, High-Throughput Technologies, Molecular Imaging, and Omics Technology), Method (Cellular Assays, Biochemical Assays, Ex-Vivo Models, and In Silico Models), Industry (Pharmaceutical & Biopharmaceutical Companies, Diagnostics, Food, Chemicals, Cosmetics & Household Products), Distribution Channel (Direct Tender, Retail Sales, and Others) Country (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2030
Overview of North America In-Vitro Toxicology Testing Market Dynamics
Driver
- Rising investment in R&D by key market players
Restraint
- complexity of biological systems
Opportunity
- Technological advancements to develop new toxicology testing methods
Market Players
Some of the major market players operating in the North America in-vitro toxicology testing market are:
- Labcorp Drug Development
- Thermo Fisher Scientific Inc.
- Charles River Laboratories
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- Catalent, Inc
- QIAGEN
- Intertek Group plc
- Lonza
- Promega Corporation
- Eurofins Scientific
- SGS Societe Generale de Surveillance SA
- Cyprotex Plc.
- Aragen Life Sciences Ltd.
- Shanghai Medicilon Inc.
- Creative Biolabs
- BioIVT
- AAT Bioquest, Inc.
- IONTOX
- Gentronix
- MB Research Laboratories
- InSphero
- Creative Bioarray
- Preferred Cell Systems
TABLE OF CONTENTS
1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 OVERVIEW OF THE NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET 17
1.4 CURRENCY AND PRICING 19
1.5 LIMITATIONS 19
1.6 MARKETS COVERED 19
2 MARKET SEGMENTATION 22
2.1 MARKETS COVERED 22
2.2 GEOGRAPHICAL SCOPE 23
2.3 YEARS CONSIDERED FOR THE STUDY 23
2.4 DBMR TRIPOD DATA VALIDATION MODEL 24
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 27
2.6 MULTIVARIATE MODELLING 28
2.7 PRODUCT AND SERVICE SEGMENT LIFELINE CURVE 28
2.8 MARKET END USER COVERAGE GRID 29
2.9 DBMR MARKET POSITION GRID 30
2.10 VENDOR SHARE ANALYSIS 31
2.11 SECONDARY SOURCES 32
2.12 ASSUMPTIONS 32
3 EXECUTIVE SUMMARY 33
4 PREMIUM INSIGHTS 36
4.1 PESTEL ANALYSIS 38
4.2 PORTERS ANALYSIS 39
5 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, INDUSTRY INSIGHTS 40
6 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, REGULATIONS 42
7 MARKET OVERVIEW 43
7.1 DRIVERS 45
7.1.1 INCREASING DEMAND FOR TOXICOLOGY TESTING PRODUCTS 45
7.1.2 RAPIDLY GROWING PHARMACEUTICAL AND MEDICAL DEVICE INDUSTRIES 45
7.1.3 RISING INVESTMENT IN R&D BY KEY MARKET PLAYERS 46
7.1.4 TECHNOLOGICAL ADVANCEMENTS TO DEVELOP NEW TOXICOLOGY TESTING METHODS 46?
7.2 RESTRAINTS 47
7.2.1 HIGH COSTS ASSOCIATED WITH IN-VITRO TOXICOLOGY TESTING AND PRODUCTS 47
7.2.2 COMPLEXITY OF BIOLOGICAL SYSTEMS 47
7.2.3 NEED FOR SKILLED PERSONNEL AND INFRASTRUCTURE 48
7.3 OPPORTUNITIES 48
7.3.1 GROWING ADOPTION OF QUALITY CHECK PRODUCTS TO PREVENT PRODUCT RECALLS 48
7.3.2 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS FOR MARKET EXPANSION 48
7.3.3 GROWING DEMAND FOR PERSONALIZED MEDICINE AND PRECISION TOXICOLOGY 49
7.4 CHALLENGES 50
7.4.1 ETHICAL AND PUBLIC PERCEPTION 50
7.4.2 REGULATORY ACCEPTANCE AND ENDORSEMENT OF IN-VITRO TESTING METHODS 50
8 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE 51
8.1 OVERVIEW 52
8.2 CONSUMABLES 55
8.3 SERVICES 56
8.3.1 CYTOTOXICITY 57
8.3.2 GENE TOXICITY 57
8.3.3 HEPATOTOXICITY 57
8.3.4 OPHTHALMIC TOXICITY 57
8.3.5 CARDIOTOXICITY 57
8.3.6 NEPHROTOXICITY 57
8.3.7 NEUROTOXICITY 58
8.3.8 OTHERS 58
8.4 ASSAYS 58
8.4.1 CELL-BASED ELISA & WESTERN BLOTS 59
8.4.2 ENZYME TOXICITY ASSAYS 59
8.4.3 RECEPTOR-BINDING ASSAYS 59
8.4.4 BACTERIAL TOXICITY ASSAYS 59
8.4.5 TISSUE CULTURE ASSAYS 59
8.4.6 OTHER ASSAYS 59
8.5 EQUIPMENTS 60
8.6 SOFTWARE 61?
9 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST 62
9.1 OVERVIEW 63
9.2 ADME (ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION) TESTING 66
9.3 CYTOTOXICITY TESTING 67
9.4 GENOTOXICITY TESTING 68
9.5 DERMAL TOXICITY TESTING 69
9.6 OCULAR TOXICITY TESTING 69
9.7 ORGAN TOXICITY TESTING 70
9.8 SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING 71
9.9 PHOTOTOXICITY TESTING 71
9.10 OTHER TOXICITY ENDPOINTS AND TESTS 72
10 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY 73
10.1 OVERVIEW 74
10.2 CELL CULTURE TECHNOLOGIES 77
10.3 HIGH-THROUGHPUT TECHNOLOGIES 78
10.4 MOLECULAR IMAGING 79
10.5 OMICS TECHNOLOGY 80
11 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD 81
11.1 OVERVIEW 82
11.2 CELLULAR ASSAYS 84
11.3 BIOCHEMICAL ASSAYS 85
11.4 EX-VIVO MODELS 86
11.5 IN SILICO MODELS 87
12 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY 88
12.1 OVERVIEW 89
12.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 92
12.2.1 CONSUMABLES 93
12.2.2 SERVICES 93
12.2.3 ASSAYS 93
12.2.4 EQUIPMENTS 93
12.2.5 SOFTWARE 93
12.3 DIAGNOSTICS 93
12.3.1 CONSUMABLES 95
12.3.2 SERVICES 95
12.3.3 ASSAYS 95
12.3.4 EQUIPMENTS 95
12.3.5 SOFTWARE 95
12.4 FOOD 95
12.4.1 CONSUMABLES 96
12.4.2 SERVICE 96
12.4.3 ASSAYS 96
12.4.4 EQUIPMENTS 97
12.4.5 SOFTWARE 97
12.5 CHEMICALS 97
12.5.1 CONSUMABLES 98
12.5.2 SERVICES 98
12.5.3 ASSAYS 98
12.5.4 EQUIPMENTS 98
12.5.5 SOFTWARE 98
12.6 COSMETICS AND HOUSEHOLD PRODUCTS 99
12.6.1 CONSUMABLES 100
12.6.2 SERVICES 100
12.6.3 ASSAYS 100
12.6.4 EQUIPMENTS 100
12.6.5 SOFTWARE 100
13 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL 101
13.1 OVERVIEW 102
13.2 DIRECT TENDER 104
13.3 RETAIL SALES 105
13.4 OTHERS 106
14 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY 107
14.1 NORTH AMERICA 108
14.1.1 U.S. 117
14.1.2 CANADA 122
14.1.3 MEXICO 127
15 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, COMPANY LANDSCAPE 132
15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 132
16 SWOT ANALYSIS 133?
17 COMPANY PROFILE 134
17.1 THERMO FISHER SCIENTIFIC INC. 134
17.1.1 COMPANY SNAPSHOT 134
17.1.2 REVENUE ANALYSIS 134
17.1.3 PRODUCT PORTFOLIO 135
17.1.4 RECENT DEVELOPMENT 135
17.2 LABCORP DRUG DEVELOPMENT 136
17.2.1 COMPANY SNAPSHOT 136
17.2.2 REVENUE ANALYSIS 136
17.2.3 PRODUCT PORTFOLIO 137
17.2.4 RECENT DEVELOPMENT 137
17.3 MERCK KGAA 138
17.3.1 COMPANY SNAPSHOT 138
17.3.2 REVENUE ANALYSIS 138
17.3.3 PRODUCT PORTFOLIO 139
17.3.4 RECENT DEVELOPMENT 139
17.4 CHARLES RIVER LABORATORIES. 140
17.4.1 COMPANY SNAPSHOT 140
17.4.2 REVENUE ANALYSIS 140
17.4.3 PRODUCT PORTFOLIO 141
17.4.4 RECENT DEVELOPMENT 141
17.5 LONZA 142
17.5.1 COMPANY SNAPSHOT 142
17.5.2 REVENUE ANALYSIS 142
17.5.3 PRODUCT PORTFOLIO 143
17.5.4 RECENT DEVELOPMENT 143
17.6 AAT BIOQUEST, INC. 144
17.6.1 COMPANY SNAPSHOT 144
17.6.2 PRODUCT PORTFOLIO 144
17.6.3 RECENT DEVELOPMENTS 144
17.7 ARAGEN LIFE SCIENCES LTD. 145
17.7.1 COMPANY SNAPSHOT 145
17.7.2 REVENUE ANALYSIS 145
17.7.3 PRODUCT PORTFOLIO 146
17.7.4 RECENT DEVELOPMENT 146?
17.8 BIOIVT 147
17.8.1 COMPANY SNAPSHOT 147
17.8.2 PRODUCT PORTFOLIO 147
17.8.3 RECENT DEVELOPMENT 147
17.9 BIO-RAD LABORATORIES, INC. 148
17.9.1 COMPANY SNAPSHOT 148
17.9.2 REVENUE ANALYSIS 148
17.9.3 PRODUCT PORTFOLIO 149
17.9.4 RECENT DEVELOPMENT 149
17.10 CATALENT, INC 150
17.10.1 COMPANY SNAPSHOT 150
17.10.2 REVENUE ANALYSIS 150
17.10.3 PRODUCT PORTFOLIO 151
17.10.4 RECENT DEVELOPMENT 151
17.11 CREATIVE BIOARRAY. 152
17.11.1 COMPANY SNAPSHOT 152
17.11.2 PRODUCT PORTFOLIO 152
17.11.3 RECENT DEVELOPMENTS 152
17.12 CREATIVE BIOLABS. 153
17.12.1 COMPANY SNAPSHOT 153
17.12.2 PRODUCT PORTFOLIO 153
17.12.3 RECENT DEVELOPMENTS 153
17.13 CYPROTEX LIMITED 154
17.13.1 COMPANY SNAPSHOT 154
17.13.2 PRODUCT PORTFOLIO 154
17.13.3 RECENT DEVELOPMENT 154
17.14 EUROFINS SCIENTIFIC 155
17.14.1 COMPANY SNAPSHOT 155
17.14.2 REVENUE ANALYSIS 155
17.14.3 PRODUCT PORTFOLIO 156
17.14.4 RECENT DEVELOPMENT 156
17.15 GENTRONIX 157
17.15.1 COMPANY SNAPSHOT 157
17.15.2 PRODUCT PORTFOLIO 157
17.15.3 RECENT DEVELOPMENT 157
17.16 IONTOX 158
17.16.1 COMPANY SNAPSHOT 158
17.16.2 PRODUCT PORTFOLIO 158
17.16.3 RECENT DEVELOPMENT 158?
17.17 INSPHERO. 159
17.17.1 COMPANY SNAPSHOT 159
17.17.2 PRODUCT PORTFOLIO 159
17.17.3 RECENT DEVELOPMENT 159
17.18 INTERTEK GROUP PLC 160
17.18.1 COMPANY SNAPSHOT 160
17.18.2 REVENUE ANALYSIS 160
17.18.3 PRODUCT PORTFOLIO 161
17.18.4 RECENT DEVELOPMENT 161
17.19 MB RESEARCH LABORATORIES 162
17.19.1 COMPANY SNAPSHOT 162
17.19.2 PRODUCT PORTFOLIO 162
17.19.3 RECENT DEVELOPMENTS 162
17.20 PREFERRED CELL SYSTEMS 163
17.20.1 COMPANY SNAPSHOT 163
17.20.2 PRODUCT PORTFOLIO 163
17.20.3 RECENT DEVELOPMENTS 163
17.21 PROMEGA CORPORATION 164
17.21.1 COMPANY SNAPSHOT 164
17.21.2 PRODUCT PORTFOLIO 164
17.21.3 RECENT DEVELOPMENTS 165
17.22 QIAGEN 166
17.22.1 COMPANY SNAPSHOT 166
17.22.2 REVENUE ANALYSIS 166
17.22.3 PRODUCT PORTFOLIO 167
17.22.4 RECENT DEVELOPMENTS 167
17.23 SGS SOCIETE GENERALE DE SURVEILLANCE SA 168
17.23.1 COMPANY SNAPSHOT 168
17.23.2 REVENUE ANALYSIS 168
17.23.3 PRODUCT PORTFOLIO 169
17.23.4 RECENT DEVELOPMENTS 169
17.24 SHANGHAI MEDICILON INC. 170
17.24.1 COMPANY SNAPSHOT 170
17.24.2 REVENUE ANALYSIS 170
17.24.3 PRODUCT PORTFOLIO 171
17.24.4 RECENT DEVELOPMENT 171
18 QUESTIONNAIRE 172
19 RELATED REPORTS 175
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security